Image courtesy of Robert S. Kirsner.
Questions
- 1.What is your diagnosis?
- a.Vitiligo.
- b.Piebaldism.
- c.Pinta.
- d.Chemical leukoderma.
- e.Albinism.
- a.
- 2.Which of the following is the most likely reason that intent-to-treat analyses are preferred over per-protocol analysis?
- a.More likely to represent a real-life experience.
- b.More likely to control for bias.
- c.More likely to have planned for sample size.
- d.More likely to show a significant difference.
- e.More likely to study a population that will use treatment in clinic.
- a.
- 3.On what was the twice-weekly dosing schedule for tacrolimus based?
- a.Previous studies performed in patients with atopic dermatitis.
- b.Previous studies performed in patients with vitiligo.
- c.Patient convenience.
- d.Searching for lowest possible effective dose.
- e.All of the above.
- a.
TOPIC ARTICLE
Questions 2 and 3 refer to the following article:
Cavalié M, Ezzedine K, Fontas E et al. (2015) Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol 135:970–4
Answers are available as supplementary material at http://dx.doi.org/10.1038/jid.2015.37.
- Supplementary Information
Article info
Publication history
JID and Logical Images, Inc., have cooperated to offer the JID VisualDx Quiz, incorporating diagnostic images from VisualDx's vast database. Questions relate to the image as well as to selected articles in JID, which are listed after the questions. Answers will be posted as supplementary material. We hope you enjoy this challenge.
Identification
Copyright
© 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
37191-8&id=fx1.jpg){kind=link}